| Active-Ingredient | Sorafenib |
|---|---|
| Indication | Liver cancer, Kidney cancer, Thyroid cancer |
| Manufacturers | Cipla Limited |
| Packaging | 120 tablets in 1 bottle |
| Strength | 200mg |
| Drug Class | Multikinase Inhibitor/Tyrosine Kinase Inhibitor (TKI) |
| Dosage Form | Oral Film-Coated Tablet |
| Delivery-Time | 6 To 15 days |
No key features available.
